Jindal R M
Department of Surgery, Indiana University School of Medicine, Indianapolis 46202, USA.
Postgrad Med J. 1997 Dec;73(866):785-93. doi: 10.1136/pgmj.73.866.785.
The correction of post-transplant hyperlipidaemia warrants the judicious and timely use of pharmacological agents with dietary modification and exercise. Reduction in hyperlipidaemia may have some role in decreasing the incidence of chronic rejection of allografts. The awareness that the morbidity and mortality of atherosclerotic disease may be lowered by active intervention will result in a better quality of life for transplant recipients.
移植后高脂血症的纠正需要合理且及时地使用药物，并配合饮食调整和运动。降低高脂血症可能在降低同种异体移植物慢性排斥反应的发生率方面发挥一定作用。认识到通过积极干预可以降低动脉粥样硬化疾病的发病率和死亡率，将有助于提高移植受者的生活质量。
